Are statin effects mediated through, or in spite of, their cholesterol-lowering action?

Angiology

Volumn 60, Issue 2, 2009, Pages 262-263

  Mascitelli, Luca ^a   Pezzetta, Francesca ^b   Goldstein, Mark R ^c  

^a Medical Service Comando Brigata Alpina Julia Udine   (Italy)

^b Cardiology Service Ospedale di Tolmezzo Tolmezzo   (Italy)

^c Fountain Medical Court ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOFIBRATE; EZETIMIBE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TORCETRAPIB;

CORONARY ARTERY DISEASE; FAMILIAL HYPERCHOLESTEROLEMIA; HORMONE SUBSTITUTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPOLIPEMIA; LETTER; MORTALITY;

CARDIOVASCULAR DISEASES; CHOLESTEROL; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 65249130546     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319708330527     Document Type: Letter

References (10)

1. Goumas GS Is there evidence-based hypolipidemic treatment with clinical benefit beyond statins? Angiology. 2008 Nov 18 [Epub ahead of print].
2. Hayward RA, Hofer TP, Vijan S. Narrative review: lack of evidence for recommended low-density lipoprotein treatment targets: a solvable problem. Ann Intern Med. 2006 ; 145: 520-530. (Pubitemid 46780956)
3. Bots ML, Visseren FL, Evans GW, et al, and the RADIANCE 2 Investigators. Torcetrapib and carotid intimamedia thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial. Lancet. 2007 ; 370: 153-160. (Pubitemid 47042895)
4. Pedone C., Carbonin P., Kastelein JJ, et al, and the ENHANCE Investigators. Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med. 2008 ; 358: 1431-43 [Erratum in: N Engl J Med 2008 ; 358: 1977 ].
5. Rossouw JE, Anderson GL, Prentice RL, et al, for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002 ; 288: 321-333. (Pubitemid 34761611)
6. W.H.O. cooperative trial on primary prevention of ischaemic heart disease using clofibrate to lower serum cholesterol: mortality follow-up. Report of the Committee of Principal Investigators. Lancet. 1980 ; 2: 379-385.
7. de Lorgeril M., Renaud S., Mamelle N., et al. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet. 1994 ; 343: 1454-1459. (Pubitemid 24176333)
8. Sacks FM, Moye LA, Davis BR, et al. Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the cholesterol and recurrent events trial. Circulation. 1998 ; 97: 1446-1452. (Pubitemid 28191299)
9. Versmissen J., Oosterveer DM, Yazdanpanah M., et al. Efficacy of statins in familial hypercholesterolaemia: a long term cohort study. BMJ. 2008 ; 337: a2423.
10. Mascitelli L., Ravnskov U., Pezzetta F., Goldstein MR After the failure of ENHANCEd cholesterol lowering in familial hypercholesterolemia, SEAS of problems with ezetimibe. Angiology. IN PRESS.